EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 50 / No 3 (September 2018) J Extra Corpor Technol, 50 3 (2018) 149-154 References
Free Access
Issue
J Extra Corpor Technol
Volume 50, Number 3, September 2018
Page(s) 149 - 154
DOI https://doi.org/10.1051/ject/201850149
Published online 15 September 2018
  1. Werho DK, Pasquali SK, Yu S, et al. Hemorrhagic complications in pediatric cardiac patients on extracorporeal membrane oxygenation: An analysis of the Extracorporeal Life Support Organization registry. Pediatr Crit Care Med. 2015;16:276–88. [CrossRef] [PubMed] [Google Scholar]
  2. Kessel AD, Kline M, Zinger M, et al. The impact and statistical analysis of a multifaceted anticoagulation strategy in children supported on ECMO: Performance and pitfalls. J Intensive Care Med. 2015;32:60. [Google Scholar]
  3. Dalton HJ, Macrae DJ; Pediatric Acute Lung Injury Consensus Conference Group. Extracorporeal support in children with pediatric acute respiratory distress syndrome: Proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015;16(5 Suppl 1):S111–7. [CrossRef] [PubMed] [Google Scholar]
  4. Oliver WC Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth. 2009;13:154–75. [CrossRef] [PubMed] [Google Scholar]
  5. Bolliger D, Zenklusen U, Tanaka KA Point-of-care coagulation management algorithms during ECMO support: Are we there yet? Minerva Anestesiol. 2016;82:1008–9. [Google Scholar]
  6. Lequier L, Massicotte MP Monitoring of anticoagulation in extracorporeal membrane oxygenation: Is anti-Xa the new activated clotting time? Pediatr Crit Care Med. 2015;16:87–9. [CrossRef] [PubMed] [Google Scholar]
  7. Bembea MM, Annich G, Rycus P, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey. Pediatr Crit Care Med. 2013;14:e77–84. [CrossRef] [PubMed] [Google Scholar]
  8. Liveris A, Bello RA, Friedmann P, et al. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*. Pediatr Crit Care Med. 2014;15:e72–9. [CrossRef] [PubMed] [Google Scholar]
  9. Gadepalli SK, Hirschl RB Extracorporeal life support: Updates and controversies. Semin Pediatr Surg. 2015;24:8–11. [CrossRef] [PubMed] [Google Scholar]
  10. Alexander DC, Butt WW, Best JD, et al. Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support. Thromb Res. 2010;125:387–92. [CrossRef] [PubMed] [Google Scholar]
  11. Mallett SV Clinical utility of viscoelastic tests of coagulation (TEG/ROTEM) in patients with liver disease and during liver transplantation. Semin Thromb Hemost. 2015;41:527–37. [CrossRef] [PubMed] [Google Scholar]
  12. Saini A, Hartman ME, Gage BF, et al. Incidence of platelet dysfunction by thromboelastography-platelet mapping in children supported with ECMO: A pilot retrospective study. Front Pediatr. 2015;3:116. [PubMed] [Google Scholar]
  13. Panigada M, Iapichino G, L'Acqua C, et al. Prevalence of “flat-line” thromboelastography during extracorporeal membrane oxygenation for respiratory failure in adults. ASAIO J. 2015;82:177–8. [Google Scholar]
  14. Saini A, Spinella PC Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation. Clin Lab Med. 2014;34:655–73. [CrossRef] [PubMed] [Google Scholar]
  15. Chan AK, Leaker M, Burrows FA, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost. 1997;77:270–7. [CrossRef] [PubMed] [Google Scholar]
  16. Hundalani SG, Nguyen KT, Soundar E, et al. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014;15:e198–205. [CrossRef] [PubMed] [Google Scholar]
  17. Vandiver JW, Vondracek TG A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring. Hosp Pract (1995). 2013;41:16–24. [CrossRef] [PubMed] [Google Scholar]
  18. Hirsh J, Raschke R Heparin and low-molecular-weight heparin: The Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):188S–203S. [CrossRef] [PubMed] [Google Scholar]
  19. Mallett SV, Chowdary P, Burroughs AK Clinical utility of viscoelastic tests of coagulation in patients with liver disease. Liver Int. 2013;33:961–74. [CrossRef] [PubMed] [Google Scholar]
  20. Dalton HJ, Reeder R, Garcia-Filion P, et al. Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation (ECMO). Am J Respir Crit Care Med. 2017;196:768–71. [Google Scholar]
  21. Dalton HJ, Garcia-Filion P, Holubkov R, et al. Association of bleeding and thrombosis with outcome in extracorporeal life support. Pediatr Crit Care Med. 2015;16:167–74. [CrossRef] [Google Scholar]
  22. Chen A, Teruya J Global hemostasis testing thromboelastography: Old technology, new applications. Clin Lab Med. 2009;29:391–407. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.